This site is intended for healthcare professionals

BeiGene announces positive topline results for global phase III trial of tislelizumab in esophageal squamous cell carcinoma.

Read time: 1 mins
Last updated:28th Jun 2021
Published:29th Jan 2021
Condition: Oesophageal Cancer
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest